Thermo Fisher Scientific Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $21.54B | $786.0M |
| FY2017 | — | $25.41B | $1.34B |
| FY2018 | $17.72B | $27.59B | $2.10B |
| FY2019 | $17.08B | $29.68B | $2.40B |
| FY2020 | $19.11B | $34.51B | $10.33B |
| FY2021 | $34.67B | $40.79B | $4.48B |
| FY2022 | $34.28B | $43.98B | $8.52B |
| FY2023 | $34.73B | $46.74B | $8.08B |
| FY2024 | $31.07B | $49.58B | $4.01B |
| FY2025 | $39.17B | $53.41B | $9.85B |